Holen Sie sich die Stockscreener-App
1.805
4.34%
0.075
Schlusskurs vom Vortag:
$1.73
Offen:
$1.73
24-Stunden-Volumen:
255.69K
Relative Volume:
0.29
Marktkapitalisierung:
$53.44M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-30.15M
KGV:
-0.4513
EPS:
-4
Netto-Cashflow:
$-21.66M
1W Leistung:
-5.50%
1M Leistung:
-15.26%
6M Leistung:
-28.66%
1J Leistung:
-38.61%
1-Tages-Spanne:
$1.73
$1.82
1-Wochen-Bereich:
$1.70
$1.995
52-Wochen-Spanne:
$1.58
$3.84
Nrx Pharmaceuticals Inc Stock (NRXP) Company Profile
Firmenname
Nrx Pharmaceuticals Inc
Sektor
Branche
Telefon
484-254-6134
Adresse
1201 ORANGE STREET, WILMINGTON
Compare NRXP vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NRXP
Nrx Pharmaceuticals Inc
|
1.805 | 51.22M | 0 | -30.15M | -21.66M | -4.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Nrx Pharmaceuticals Inc Stock (NRXP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-04-02 | Eingeleitet | BTIG Research | Buy |
Nrx Pharmaceuticals Inc Aktie (NRXP) Neueste Nachrichten
How NRx Pharmaceuticals Inc. stock benefits from global expansionMarket Growth Review & Daily Volume Surge Trade Alerts - mfd.ru
What’s the beta of NRx Pharmaceuticals Inc. stockTrade Exit Summary & High Conviction Buy Zone Alerts - mfd.ru
Is NRx Pharmaceuticals Inc. stock a buy before product launchesWeekly Loss Report & Technical Confirmation Alerts - mfd.ru
What’s the MACD signal for NRx Pharmaceuticals Inc.July 2025 Highlights & Entry and Exit Point Strategies - mfd.ru
Market Recap: Can NRx Pharmaceuticals Inc Equity Warrant weather a recessionRisk Management & Verified Entry Point Detection - baoquankhu1.vn
Inflation Data: Is NRx Pharmaceuticals Inc. Equity Warrant likely to announce a buybackMarket Growth Summary & Weekly Momentum Picks - baoquankhu1.vn
Aug Gainers: Will NRx Pharmaceuticals Inc stock hit new highs in YEARJuly 2025 Recap & Fast Gain Swing Trade Alerts - baoquankhu1.vn
NRx Pharmaceuticals appoints Joseph M. Casper as chief operating officer By Investing.com - Investing.com Australia
NRx Pharmaceuticals appoints Joseph M. Casper as chief operating officer - Investing.com
FDA fast track puts ketamine-based therapy in spotlight for suicide care - MSN
Market Review: Can NRx Pharmaceuticals Inc Equity Warrant maintain its current growth rateEarnings Overview Report & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Published on: 2026-01-31 19:02:41 - baoquankhu1.vn
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Sees Significant Increase in Short Interest - MarketBeat
NRx Pharmaceuticals completes debt repayment, ends 2025 debt-free - MSN
NRx Pharmaceuticals (NASDAQ:NRXP) Stock Rating Lowered by Zacks Research - MarketBeat
Movement Recap: How does NRx Pharmaceuticals Inc perform in inflationary periodsSwing Trade & Real-Time Stock Entry Alerts - baoquankhu1.vn
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Volatility Watch: How volatile is NRx Pharmaceuticals Inc Equity Warrant stockPortfolio Return Summary & Step-by-Step Trade Execution Guides - baoquankhu1.vn
Breakout Zone: Should value investors consider Sprouts Farmers Market IncInsider Buying & Real-Time Stock Entry Alerts - baoquankhu1.vn
What is the dividend yield of NRx Pharmaceuticals Inc. Equity Warrant2025 Geopolitical Influence & Weekly High Return Stock Opportunities - mfd.ru
NRx Pharmaceuticals (NASDAQ: NRXP) sets virtual annual meeting for March - MSN
Aug Catalysts: Is NRx Pharmaceuticals Inc Equity Warrants growth already priced inQuarterly Trade Summary & AI Optimized Trading Strategy Guides - baoquankhu1.vn
NRx Pharmaceuticals (NASDAQ: NRXP) Sets Virtual Annual Meeting for March - mychesco.com
FDA Fast Track Puts Ketamine-Based Therapy in Spotlight for Suicide Care - mychesco.com
Analysts’ Opinions Are Mixed on These Healthcare Stocks: NRX Pharmaceuticals (NRXP) and Qiagen (QGEN) - The Globe and Mail
H.C. Wainwright reiterates Buy rating on NRx Pharmaceuticals stock at $40 - Investing.com Nigeria
H.C. Wainwright reiterates Buy rating on NRx Pharmaceuticals stock at $40 By Investing.com - Investing.com India
Short Squeeze: What is the dividend yield of NRx Pharmaceuticals IncPortfolio Gains Summary & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Pullback Watch: Can GRDN withstand a market correctionTrade Ideas & Pattern Based Trade Signal System - baoquankhu1.vn
NRXP Stock: Ascendiant Capital Raises Price Target to $48 | NRXP - GuruFocus
NRx Pharmaceuticals Addresses Nasdaq Meeting Compliance Requirements - The Globe and Mail
Milestone Patient Data Eclipsing 70,000 on Real World Use - openPR.com
NRx Pharmaceuticals Received Notice of Noncompliance - TradingView
NRx Pharmaceuticals Announces 2025 Annual Meeting Date and Record Date - citybiz
NRx Pharmaceuticals (Nasdaq:NRXP) Announces 2025 Annual Meeting Date and Record Date - The Manila Times
Sentiment Review: What are NRx Pharmaceuticals Incs recent SEC filings showingPortfolio Return Summary & AI Forecasted Entry/Exit Points - baoquankhu1.vn
NRx Pharmaceuticals Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be submitted to the FDA in Support of NRX-100 Approval - marketscreener.com
Biotech NRx Pharma outlines its business at H.C. Wainwright investor event - Stock Titan
NRx Pharmaceuticals (NASDAQ:NRXP) Given "Buy" Rating at BTIG Research - MarketBeat
NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval - Sahm
Milestone Patient Data Eclipsing 70,000 on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) - Barchart.com
FinancialContentMilestone Patient Data Eclipsing 70,000 on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) - FinancialContent
NRx Pharmaceuticals (NASDAQ: NRXP) Licenses Real-World Evidence From 70,000 Patients to Support FDA Accelerated Approval of NRX-100 - Digital Journal
NRx Pharmaceuticals Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression - citybiz
NRXP stock slips premarket as NRx says FDA fast-tracked ketamine bid with 70,000-patient dataset - TechStock²
About Us - FinancialContent
NRx Pharma Strengthens NRX-100 Approval Case With 70,000-Patient Real-World Ketamine Data - Nasdaq
Why Did NRXP Stock Surge 21% Pre-Market Today? - Stocktwits
NRx Pharmaceuticals' NRX-100 Receives FDA Fast Track Designation for Treatment of Suicidal Ideation in Depression and Bipolar Depression - Quiver Quantitative
Finanzdaten der Nrx Pharmaceuticals Inc-Aktie (NRXP)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):